A Science and Technology Blog
If WHO, CDC and the U.S. Surgeon General were equally responsible for the public health message disaster of discouraging mask use by the public to cut the transmission risk of…
Children (including infants) younger than 18 years generally have only mild COVID-19 disease, and deaths were less than 1%. However, 8% of children develop a severe form of the disease…
The results of the Phase-1 clinical trial of the Oxford vaccine (ChAdOx1 nCoV-19) to prevent infection by novel coronavirus are expected by the first week of July. Serum Institute of…
While a single dose induced antigen-specific antibody and T cells responses in pigs, the booster dose enhanced the antibody responses with a significant increase in neutralising antibody levels. There was…
An advisory from the Indian government that an email with a government email address (ncov19@gov.in) may be a phishing campaign from hackers in China appears silly, at best. That is…
Gilead plans to begin a Phase-1 clinical trial in August of an inhaled version of remdesivir for early-stage COVID-19 treatment outside of hospital settings. The drug is currently approved for…
Unmindful of the high positive cases reported daily, Maharashtra has tested aggressively, while Delhi has done the opposite. Kerala, Karnataka and Andhra Pradesh have performed excellently, while Bihar, Uttar Pradesh,…
The researchers found passive transfer of neutralising antibodies isolated from convalescent plasma into Syrian hamsters protect the animals against the disease when exposed to the virus and also protects hamsters…
